ANXA2 and glioblastoma: Our study differs from the previous proteomics analysis where two different PDX glioblastoma models (angiogenic or invasive) were compared.25 In the latter analysis, Annexin A2 (ANXA2) and Calnexin (CNX) were found upregulated in the angiogenic model.